author-photo

Elizabeth Luebbe

University of Rochester

28

Papers

479

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

The Spinal Muscular Atrophy Health Index (SMA-HI): A Novel Outcome for Measuring How a Patient Feels and Functions.

2021 Muscle & Nerve
Show All
- Source
- Cite
- Save
Citations (0)
Mexiletine in myotonic dystrophy type-1: A randomized, double-blind, placebo-controlled trial.

2020 Neurology
Show All
- Source
- Cite
- Save
Citations (3)
Myotonic dystrophy patient preferences in patient-reported outcome measures

2018 Muscle & Nerve
Show All
- Source
- Cite
- Save
Citations (4)
Pain and pain medication use in patients with myotonic dystrophy type 1 (DM1) and type 2 (DM2)

2017
Show All
- Source
- Cite
- Save
Citations (0)
What Matters Most: A Perspective From Adult Spinal Muscular Atrophy Patients

2016 Journal of neuromuscular diseases
Show All
- Source
- Cite
- Save
Citations (8)
Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy

2016 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (5)
Three Year Natural History of Motor Impairment in Myotonic Dystrophy Type 1 (DM1) (P1.130)

2016 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy

2016 Developmental Medicine & Child Neurology
Show All
- Source
- Cite
- Save
Citations (29)
Statin and other antihyperlipidemic medication use and side effects in myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2)

2015
Show All
- Source
- Cite
- Save
Citations (0)
Myotonic Dystrophy Health Index: Initial evaluation of a disease‐specific outcome measure

2014 Muscle & Nerve
Show All
- Source
- Cite
- Save
Citations (36)